Physical activity and autoimmune diseases: Get moving and manage the disease

K Sharif, A Watad, NL Bragazzi, M Lichtbroun… - Autoimmunity …, 2018 - Elsevier
Physical activity, by definition, is any skeletal muscle body movement that results in energy
expenditure. In the last few decades, a plethora of scientific evidences have accumulated …

Outcome measures in clinical trials for multiple sclerosis

CEP van Munster, BMJ Uitdehaag - CNS drugs, 2017 - Springer
Due to the heterogeneous nature of the disease, it is a challenge to capture disease activity
of multiple sclerosis (MS) in a reliable and valid way. Therefore, it can be difficult to assess …

[HTML][HTML] Effect of high-dose simvastatin on brain atrophy and disability in secondary progressive multiple sclerosis (MS-STAT): a randomised, placebo-controlled …

J Chataway, N Schuerer, A Alsanousi, D Chan… - The Lancet, 2014 - thelancet.com
Background Secondary progressive multiple sclerosis, for which no satisfactory treatment
presently exists, accounts for most of the disability in patients with multiple sclerosis …

[KSIĄŻKA][B] Шкалы, тесты и опросники в неврологии и нейрохирургии

А Белова - 2020 - books.google.com
Книга посвящена вопросам использования опросников, тестов и шкал для оценки
состояния неврологических больных и определения эффективности лечения …

Measuring the impact of MS on walking ability: the 12-Item MS Walking Scale (MSWS-12)

JC Hobart, A Riazi, DL Lam**, R Fitzpatrick… - Neurology, 2003 - neurology.org
Objective: To develop a patient-based measure of walking ability in MS. Methods: Twelve
items describing the impact of MS on walking (12-Item MS Walking Scale [MSWS-12]) were …

Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity

R Roxburgh, SR Seaman, T Masterman, AE Hensiek… - Neurology, 2005 - neurology.org
Background: There is no consensus method for determining progression of disability in
patients with multiple sclerosis (MS) when each patient has had only a single assessment in …

[HTML][HTML] Improving the evaluation of therapeutic interventions in multiple sclerosis: the role of new psychometric methods

J Hobart, S Cano - Health technology assessment, 2009 - journalslibrary.nihr.ac.uk
Objectives In this monograph we examine the added value of new psychometric methods
(Rasch measurement and Item Response Theory) over traditional psychometric approaches …

Primary-progressive multiple sclerosis

DH Miller, SM Leary - The Lancet Neurology, 2007 - thelancet.com
Summary About 10–15% of patients with multiple sclerosis (MS) present with gradually
increasing neurological disability, a disorder known as primary-progressive multiple …

Daclizumab HYP versus interferon beta-1a in relapsing multiple sclerosis

L Kappos, H Wiendl, K Selmaj, DL Arnold… - … England Journal of …, 2015 - Mass Medical Soc
Background Daclizumab high-yield process (HYP) is a humanized monoclonal antibody that
binds to CD25 (alpha subunit of the interleukin-2 receptor) and modulates interleukin-2 …

Physical activity and quality of life in multiple sclerosis: intermediary roles of disability, fatigue, mood, pain, self-efficacy and social support

RW Motl, E McAuley, EM Snook… - Psychology, health & …, 2009 - Taylor & Francis
Physical activity has been associated with a small improvement in quality of life (QOL)
among those with multiple sclerosis (MS). This relationship may be indirect and operate …